Details for 2017722943

Up to date per 02.04.2026

Actions

Title / Product Name

SELADELPAR ZUR BEHANDLUNG VON PRIMÄR BILIÄRE CHOLANGITIS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017722943

EP Publication Number

3463328

E-Number

1497960

Language

PCT Number

US17029620

Publication Date

10.04.2019 A

15.06.2022 B1

Registration Date

15.06.2022

AT Publication Date

15.07.2022

Application Date

26.04.2017

Registration Number

Priorities

31.05.2016

201662343688 P

IPC

A61K 31/192 20060101AFI20171208BHEP

Maximum Duration of Protection

26.04.2037

Owner

CymaBay Therapeutics, Inc.7575 Gateway Boulevard, Suite 110 Newark, CA 94560US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

BOUDES, Polc/o CymaBay Therapeutics, Inc. 7575 Gateway Boulevard Suite 110 Newark, CA 94560US

MCWHERTER, Charles, A.c/o CymaBay Therapeutics, Inc. 7575 Gateway Boulevard Suite 110 Newark, CA 94560US

Information about Fees